Recalls / Class II
Class IID-0437-2024
Product
Rifampin Capsules USP, 300mg, 30-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Aurangabad 431 210 India, NDC 6818-0659-06
- Affected lot / code info
- Lot #: A201064, Exp. Date March 2024
Why it was recalled
Subpotent Drug
Recalling firm
- Firm
- Lupin Pharmaceuticals Inc.
- Notification channel
- Letter
- Type
- Voluntary: Firm initiated
- Address
- Harborplace Tower, 111 S Calvert St Fl 21st, Baltimore, Maryland 21202-6174
Distribution
- Quantity
- 26,352 bottles
- Distribution pattern
- Nationwide within the United States
Timeline
- Recall initiated
- 2024-03-21
- FDA classified
- 2024-04-05
- Posted by FDA
- 2024-04-17
- Terminated
- 2025-04-04
- Status
- Terminated
Source: openFDA Drug Enforcement endpoint. Recall record D-0437-2024. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.